| scholarly article | Q13442814 |
| P50 | author | Caroline Perner | Q61479434 |
| P2093 | author name string | Thomas Fischer | |
| Florian H Heidel | |||
| Tina M Schnöder | |||
| Denise Wolleschak | |||
| Caroline Ebert | |||
| P2860 | cites work | Jakpot! New small molecules in autoimmune and inflammatory diseases | Q27001957 |
| Intracellular retention of ABL kinase inhibitors determines commitment to apoptosis in CML cells | Q28481327 | ||
| Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis | Q33391880 | ||
| Ruxolitinib versus standard therapy for the treatment of polycythemia vera. | Q33420037 | ||
| ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. | Q38107993 | ||
| Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib. | Q38150978 | ||
| Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance | Q38243832 | ||
| P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387. | Q39130447 | ||
| JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms | Q41127061 | ||
| JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms | Q41138516 | ||
| Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function. | Q54254821 | ||
| Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? | Q54393708 | ||
| MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure | Q58023697 | ||
| Development of imatinib and dasatinib resistance: dynamics of expression of drug transportersABCB1, ABCC1, ABCG2, MVP, and SLC22A1 | Q60447894 | ||
| Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease | Q87635679 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ruxolitinib | Q7383611 |
| P304 | page(s) | e81-5 | |
| P577 | publication date | 2015-11-20 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | Expression and function of ABC-transporter protein ABCB1 correlates with inhibitory capacity of Ruxolitinib in vitro and in vivo | |
| P478 | volume | 101 |
Search more.